DNLI

DENALI THERAPEUTICS INC

Healthcare | Mid Cap

-$0.74

EPS Forecast

$1.19

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31T00:00:00 soon
NVAXNovavax IncNBIXNeurocrine Biosciences IncRGENRepligen CorpTECHBio-techne CorpCRSPCrispr Therapeutics AgMRNAModerna IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncREPLReplimune Group Inc